06/23/2025
6:42 PM | Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
8:16 PM | Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:42 PM | Axsome Therapeutics (Subject)
Murdock Hunter R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2025
3:17 PM | Axsome Therapeutics (Subject)
Murdock Hunter R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
6:00 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
6:00 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
6:00 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
6:00 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
6:00 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
6:24 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for AXSM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Axsome Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/29/2025
6:00 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
8:52 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
3:45 PM | Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
3:46 PM | Axsome Therapeutics (Subject)
Jacobson Mark L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
8:46 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:54 PM | Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
7:09 AM | Axsome Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
05/13/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
3:47 PM | Axsome Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2025
6:33 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
3:31 PM | Axsome Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
3:32 PM | Axsome Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
3:33 PM | Axsome Therapeutics (Filer)
| Form ARS | |
04/01/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
6:56 PM | Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:57 PM | Axsome Therapeutics (Issuer)
Maizel Ari (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:59 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:00 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:02 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:51 PM | Axsome Therapeutics (Issuer)
TABUTEAU HERRIOT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:53 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:54 PM | Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:20 PM | Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
8:00 AM | Axsome Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Jeff Bezos Launches "ChatGPT Killer"? (Ad) Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% of his time focused on AI… but Nova is only part of the story.
Behind the scenes, Amazon has been quietly investing in a breakthrough called “Helios” tech—a core enabler of the $40 trillion AI revolution. While Nova grabs headlines, this technology could be what truly transforms Amazon’s future.
But one tiny startup—not Amazon—may offer the bigger upside. Get the name of the small company at the center of the $40 trillion AI boom. |
01/13/2025
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
6:56 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
8:43 AM | Axsome Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
5:23 PM | Axsome Therapeutics (Issuer)
Maizel Ari (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
4:24 PM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
6:00 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:32 PM | Axsome Therapeutics (Subject)
Saad Mark E (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:27 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
